Christopher J. Smalley

Chris Smalley has recently retired from Merck, where he had responsibility for innovative implementation and validation, including Single Use Systems, globally. Previously, he had been Director of Quality Operations for Wyeth Pharmaceuticals for 12 years with responsibility for setting validation standards and validation activities globally. His research experience includes responsibility for Quality in the U.S. operations of the Sanofi Research Division, and earlier he had worked for the Johnson & Johnson family of companies, where he was a Plant Manager. Chris is a graduate of the Philadelphia College of Pharmacy of the University of the Sciences in Philadelphia. His graduate education includes a MBA from Temple University Fox School of Business, a Masters of Science in Pharmaceutical Chemistry from Temple University School of Pharmacy, and a Ph.D. in Healthcare Administration from LaSalle University.<br><br>
Chris is currently a member of the ISPE Disposables CoP, and serves on the Pharmaceutical Engineering Committee (PEC).

Related Articles

Risk Management in Single-Use Technology
Features
Risk Management in Single-Use Technology

Risk management is pervasive throughout the biopharmaceutical industry. It is an important factor during the implementation of new equipment or procedures into an operation. Likewise, risk management is also key when assessing the impact of changes. When doing a root cause analysis, evaluation of the risks becomes central to define the potential solutions to the problem analyzed and to...

Article
Technical
An Introduction to Predictive Maintenance

Much has been published on advantages of predictive maintenance, yet many do not realize that it is a tool to help achieve their facility's goals and objectives. If you need to convince management of the need for PredM, this article contains information that you can use as an "elevator speech."